Lygos, a company founded by BioE PhD alumni Jeff Dietrich and Eric Steen, has been in the news for their newly announced breakthrough in the production of malonic acid. The acid is a high-value chemical useful for production of pharmaceuticals, flavors, fragrances, and specialty materials. The new process, using engineered microbes, would be cheaper and less polluting than the current petroleum-intensive production methods.
For the second year in a row, UC San Francisco’s four schools topped the nation in federal biomedical research funding in their fields in 2014, with the graduate-level university as a whole receiving the most of any public recipient and second most overall in funds from the National Institutes of Health (NIH), according to annual NIH figures.
Jay Keasling and Richard Mathies, UC Berkeley professors and faculty of the graduate program in bioengineering, have been named fellows of the National Academy of Inventors. NAI fellows are nominated by their peers for outstanding contributions to innovation in areas such as patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation.
Several members of the bioengineering graduate program have received research grants in the highly competitive first wave of National Institutes of Health (NIH) awards to support President Obama’s BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative.
The Siebel Foundation has announced the names of five UC Berkeley Bioengineering graduate students who have been named Siebel Scholars.The Siebel Scholars program recognizes outstanding graduate students from the world’s most prestigious business, computer science, and bioengineering graduate schools. Each of the Class of 2015 Siebel Scholars will receive a $35,000 award for his or […]